Jubilant Pharmova

Price chart

Previous close

₹942.95

Open

₹942.95

Day high

₹975.00

Day low

₹933.85

Listed on NSE since 16 June 2003.

Market value

₹15,292 Cr

P/E (trailing)

43.70

EPS (trailing)

₹22.09

Price to book

2.16

Dividend yield

0.53%

Debt to equity

0.51

Profit margin

4.1%

Beta

0.50

Volume today

71,007

Average volume

3.05 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Jubilant Pharmova’s results filed with NSE, consolidated (the whole group). Net profit is the share of Jubilant Pharmova’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Jubilant Pharmova’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of pulmonary embolism, cancer, coronary artery disease, and other diseases. Its Allergy Immunotherapy segment provides specialized diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacture, distribution, sale, and marketing of generic formulations for therapeutic areas, such as cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment provides drug discovery services and active pharmaceutical ingredients. Its Proprietary Novel Drugs segment offers patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organizations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Noida

Employees

5,657

Company website · Profile: Yahoo Finance

No headlines name Jubilant Pharmova in the last day or two.

• Dividend - Rs 5 Per Share

  Dividend · ex-date 24 July 2026

• Dividend - Rs 5 Per Share

  Dividend · ex-date 25 July 2025

• Dividend - Rs 5 Per Share

  Dividend · ex-date 2 August 2024

• Dividend - Rs 5 Per Share

  Dividend · ex-date 10 August 2023

• Dividend - Rs 5 Per Share

  Dividend · ex-date 11 August 2022 · record date 12 August 2022

• Dividend - Rs 5 Per Share

  Dividend · ex-date 5 August 2021 · record date 6 August 2021

• Demerger

  Action · ex-date 4 February 2021 · record date 5 February 2021

• Interim Dividend - Rs 5 Per Share

  Dividend · ex-date 9 March 2020 · record date 11 March 2020

Source: NSE. Latest first, 8 of 20.